Literature DB >> 22277740

Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.

Ralph H B Benedict1, Audrey Smerbeck, Rajavi Parikh, Jonathan Rodgers, Diego Cadavid, David Erlanger.   

Abstract

BACKGROUND: Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies. The Symbol Digit Modalities Test (SDMT) is a particularly promising tool due to its sensitivity and robust correlation with brain magnetic resonance imaging (MRI) and vocational disability. Unfortunately, there are no validated alternate SDMT forms, which are needed to mitigate practice effects.
OBJECTIVE: The aim of the study was to assess the reliability and equivalence of SDMT alternate forms.
METHODS: Twenty-five healthy participants completed each of five alternate versions of the SDMT - the standard form, two versions from the Rao Brief Repeatable Battery, and two forms specifically designed for this study. Order effects were controlled using a Latin-square research design.
RESULTS: All five versions of the SDMT produced mean values within 3 raw score points of one another. Three forms were very consistent, and not different by conservative statistical tests. The SDMT test-retest reliability using these forms was good to excellent, with all r values exceeding 0.80.
CONCLUSIONS: For the first time, we find good evidence that at least three alternate versions of the SDMT are of equivalent difficulty in healthy adults. The forms are reliable, and can be implemented in clinical trials emphasizing cognitive outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22277740     DOI: 10.1177/1352458511435717

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  31 in total

1.  Neurosonological and cognitive screening for evaluation of systemic sclerosis patients.

Authors:  B R Sakr; R E Rabea; A M Aboulfotooh; N A Kishk
Journal:  Clin Rheumatol       Date:  2019-02-26       Impact factor: 2.980

2.  The influence of differences in neurocognitive function on lower limb kinematics, kinetics, and muscle activity during an unanticipated cutting motion.

Authors:  Satoshi Shibata; Masahiro Takemura; Shumpei Miyakawa
Journal:  Phys Ther Res       Date:  2018-08-30

3.  The computer-based Symbol Digit Modalities Test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients.

Authors:  Sandra Bigi; R A Marrie; C Till; E A Yeh; N Akbar; A Feinstein; B L Banwell
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

4.  A validation study for remote testing of cognitive function in multiple sclerosis.

Authors:  Lisa F Barcellos; Mary Horton; Xiaorong Shao; Kalliope H Bellesis; Terrence Chinn; Emmanuelle Waubant; Nandini Bakshi; Jackie Marcus; Ralph Hb Benedict; Catherine Schaefer
Journal:  Mult Scler       Date:  2020-07-14       Impact factor: 6.312

5.  Anxiety state affects information processing speed in patients with multiple sclerosis.

Authors:  Benedetta Goretti; R G Viterbo; E Portaccio; C Niccolai; B Hakiki; E Piscolla; P Iaffaldano; M Trojano; M P Amato
Journal:  Neurol Sci       Date:  2013-09-27       Impact factor: 3.307

Review 6.  Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.

Authors:  Daniel Ontaneda; Robert J Fox; Jeremy Chataway
Journal:  Lancet Neurol       Date:  2015-02       Impact factor: 44.182

7.  Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.

Authors:  Brian M Sandroff; Rachel E Klaren; Lara A Pilutti; Deirdre Dlugonski; Ralph H B Benedict; Robert W Motl
Journal:  J Neurol       Date:  2013-12-10       Impact factor: 4.849

Review 8.  Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.

Authors:  Shumita Roy; Ralph H B Benedict; Allison S Drake; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

9.  Alterations in functional connectivity are associated with white matter lesions and information processing efficiency in multiple sclerosis.

Authors:  José Miguel Soares; Raquel Conde; Ricardo Magalhães; Paulo Marques; Rosana Magalhães; Luciana Gomes; Óscar F Gonçalves; Mavilde Arantes; Adriana Sampaio
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

10.  iCAMS: Assessing the Reliability of a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) Tablet Application.

Authors:  Meghan Beier; Kevin Alschuler; Dagmar Amtmann; Abbey Hughes; Renee Madathil; Dawn Ehde
Journal:  Int J MS Care       Date:  2020 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.